Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Modified Live Virus
442 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
442
Total Reports
42
Deaths Reported
950.0%
Death Rate
Active Ingredients
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Modified Live Virus
Administration Routes
SubcutaneousParenteralUnknownOralOtherSubconjunctival
Species Affected
Dog 442
Most Affected Breeds
Retriever - Labrador 49
Retriever - Golden 38
Chihuahua 25
Shih Tzu 22
Shepherd Dog - Australian 22
Dachshund (unspecified) 14
Pug 14
Terrier - Yorkshire 13
Shepherd Dog - German 12
Boxer (German Boxer) 12
Most Reported Reactions
Vomiting 162
Diarrhoea 60
Lethargy (see also Central nervous system depression in 'Neurological') 55
Facial swelling (see also 'Skin') 46
Other abnormal test result NOS 43
Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 41
Anaphylaxis 39
Death 32
Lethargy (see also Central nervous system depression in Neurological) 31
Pale mucous membrane 29
Not eating 29
Facial swelling (see also Skin) 22
Outcome Breakdown
Recovered/Normal
176 (39.7%)
Outcome Unknown
148 (33.4%)
Ongoing
77 (17.4%)
Died
35 (7.9%)
Euthanized
7 (1.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.